While the United States was cleaning up the rubble of 9/11, the World Health Organization met in Shanghai, China, to discuss some business. The subject was the wealth of antiviral chemicals in a plant native to China: artemisia annua. They decided to break the plant up into several chemicals and sell the drugs in different combinations. (Later they would call to stop the use of the actual leaf of the plant in favor of their chemicals altogether).

On May 23, 1967, China began a study of natural plants to find something that would help North Vietnam fight Malaria and win the war against the United States. People call it Project 523, based on the May 23 start date. The discovery and isolation of artemisin from artemisia resulted in the Nobel Prize committee rewarding the Nobel Prize to Chinese scientist Tu Youyou later in 2015. It quickly replaced Cinchona Bark Quinine derivatives chloraquine and hydroxychloraquine for use against Malaria because it was much safer. (When the FDA suspended the EMA for hydroxycloraquine for COVID-19 in spring 2020, one of the reasons they noted as the basis of their suspension was that artemisin derivatives were safer).

STOCKHOLM, SWEDEN – DECEMBER 10: Chief Professor Tu Youyou, laureate of the Nobel Prize in Physiology or Medicine acknowledges applause after she received her Nobel Prize from King Carl XVI Gustaf of Sweden during the Nobel Prize Awards Ceremony at Concert Hall on December 10, 2015 in Stockholm, Sweden. (Photo by Pascal Le Segretain/WireImage)

Tu Youyou said this in her biographical text at the Nobel Prize: The Ministry of Health of China organized a number of full-time training courses in the late 1950s in which scientists with Western medical backgrounds were given opportunities for systemic training on the traditional Chinese medicine. In my two and a half year training program, I learned traditional Chinese medical theory and gained experience from clinical practice. Another training program I attended was on the processing (炮制) of Chinese Materia Medica.

The World Health Organization met in Shanghai, China in November of 2001 for what they described in a report as a “Meeting on Antimalarial Drug Development.” They discussed three main compounds in artemisia annua that had antiviral properties: artemether, artemisinin, and artesunate. They noted that trials were underway at this point in 2001 for dihydroartemisinin (in China) and artesunate (outside China). (Table 9 &10).

Although isolating a single chemical could be useful, breaking the plant up into several compounds destroys any effects between the compounds that were dependent on each other. People have been calling the interrelated effects between compounds the Entourage Effect since Ben-Shabat et al published a study on the interdependent effects of other compounds with THC in July 1998 in An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Anyone who has smoked marijuana, and also taken CBD and THC in chemical derivative forms, can tell you that the effects of marijuana are much different and generally preferable than using CBD or THC alone.

Of course it breaking the plant up had another effect. It gave the pharmaceutical companies a highly profitable effective monopoly over the antiviral effects the plant. There’s some profit in providing good seed stock, but nowhere near as much.

At the Shanghai meeting, the WHO discussed the use of genetic modification to increase a desirable compounds in artemisia annua, artemisinin for harvest by the Pharmaceutical companies. Quote: “the Chinese Science Academy has been working with others to increase the artemisinin content of qunghaosu using genetic techniques.” This is an extremely important point and I’ll take a moment on it.

The WHO claims to be opposed to the use of natural forms of artemisia annua because the use of natural herbs is “unscientific.” They claim that proper amounts of chemicals are necessary to clear a virus completely from the system. (Note that the mRNA vaccines used for COVID-19 do not kill the virus at all, just provide temporary immunity and spread it).

Here is some text from WHO in The use of non- pharmaceutical forms of Artemisia: Too short treatments or too low blood levels of artemisinin will result in either failure to clear parasites from the blood or high levels of recrudescence. Artemesia annua contains varying levels of artemisinin. Herbal remedies prepared using A. annua with significant artemisinin content may improve symptoms, but are likely to result in high recrudescence rates.

The Pharmaceutical masters of the WHO know exactly how much is necessary of a single compound to clear the virus. They growing genetically modified versions of the plant before 2001 to harvest their chemical compounds. They own seed stock with known yields that could be used in areas affected by Malaria. The WHO could provide testing of locally grown natural herbs to determine yield of compounds, but do not do so. Further, their argument is based on one single compound in a plant that has multiple antiviral compounds.

The pharmaceutical companies with produce artemisia derivatives for Malaria are also the largest contributors to the WHO. Sarah Staub, of the University of Florida Department of Anthropology reports that 69% of Pharmaceutical contributions to the WHO in 2015 were provided by companies that produced artemisia derivatives. Staub: “Pharmaceutical industry contributions- $30,275,130- $20,920,096 million of that coming from 3 pharmaceutical companies that produce the ACT malaria medicine or vaccine – GSK, Novartis, Sanofi Pasteur. Staub’s Powerpoint Presentation in .pdf form is available here: The World Health Organization and Artemisia annua. The presentation complements this article well and is a must read that about the WHO’s “Corruption and Malaria.”

The market for artemisia derivatives was “only” $655 million in 2020. A screenshot of revenue below is from a good report by Creedence Research. I believe that whole leaf artemisia annua can be a cheap and effective treatment against COVID-19, as do others. Creedence Research analyzed the impacts of COVID-19 on sales, but if you want the details, it will cost you $4,325: “The report covers comparative analysis of global Artemisinin Derivatives market on the basis of pre and post COVID 19 scenarios.” The section analyzing the Artemisinin Derivates market based of COVID-19 scenarios was not included in the free summary.

May 04, 2020. The World Health Organization (WHO) said on Monday that medicinal plants such as Artemisia annua, touted as possible treatments for COVID-19, should be tested for efficacy and side effects.  …. “Even if therapies are derived from traditional practice and natural, establishing their efficacy and safety through rigorous clinical trials is critical,” the sub-Saharan Africa regional office of the WHO said in the statement. …. “Many plants and substances are being proposed without the minimum requirements and evidence of quality, safety and efficacy,” it said. WHO cautions against untested COVID-19 traditional remedies

May 04, 2020. As the world reels under the new novel coronavirus crisis, countries in Africa are already importing a ‘cure.’  The countries of Tanzania, Congo-Brazzaville, and Guinea-Bissau in Africa are importing a herbal tonic from Madagascar which is being dubbed as the cure to coronavirus, even though the World Health Organization has remained firm on its stand that there are no proof of any definite cure yet. The tonic is produced from the artemisia plant, which is one of the sources of an ingredient used in a malaria treatmentreports the BBC. News 18.

The WHO opposed the use of artemisia and other established antiviral medicines as the waited for vaccines. If you’ll compare the death toll of COVID-19 in Africa to the rest of the world, it’s obvious that Africa got it right. Even the WHO’s own data obviously says so.

On August 8, 2021, the WHO finally announced a study testing aresunate (a compound form artemisia) against Covid-19: WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs. Although I believe the whole leaf with multiple compounds is best, I aquestion why they would delay testing the single promising compound artesunate for so long. Bear in mind that a study in China published in 2005 identified artemisia annua as a plant that killed SARS 1 “in vitro.” So it’s not like these medical professionals were unaware of the potential of artemisia annua to treat SARS 2. There was even a study published in the US in January 2021 on artemisia annua and SARS 2 that contained very good results.

October 6, 2021. What do you know. The WHO recommends a new vaccine for Malaria. “This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Using this vaccine on top of existing  tools to prevent malaria could save tens of thousands of young lives each year.” Over 400,000 a year have been dying under the leadership of Dr Tedros Adhanom Ghebreyesus as he blocks the use of cheap natural sources of antimalarial medicine. Now he celebrates the potential to save a fraction of those lives as his Vaccine masters role out a new chemical.

As further evidence of the WHO’s collusion with the pharmaceutical industry, consider this 2010 report from ABC News: June 5, 2010 — Scientists who advised the World Health Organization on its influenza policies and recommendations—including the decision to proclaim the so-called swine flu a “pandemic” had close ties to companies that manufacture vaccines and antiviral medicines like Tamiflu, a fact that WHO did not publicly disclose. The links between the advisors and the companies that make money from vaccines and flu treatments were detailed in a report published online by the British medical journal BMJ, which investigated the advisors’ role in WHO’s policy. World Health Organization Scientists Linked to Swine Flu Vaccine Makers


POSTSCRIPT- ROLE OF CHINA IN FORMATION OF THE WHO

April 15, 1945. Echo Wall: “Some might be surprised to learn that there is a “China story” behind the formation of the World Health Organization. That story begins, in fact, in the city of San Francisco. It is April 1945, and 37 year-old Szeming Sze, a Chinese medical school graduate from Cambridge University who for the past five years has worked at St Thomas’s Hospital in London, is among the delegates attending the San Francisco Conference. This is the convention of international delegates, led by the United States, that resulted ultimately in the establishment of the United Nations.” At a luncheon in San Francisco on April 15, 1945, on the eve of the fall of Berlin to Allied forces, Sze and Souza began discussing the urgent need for the creation of an active global health organization in light of the end of the war. Their hope was that this topic could be added to the conference agenda.” FDR had died just three days earlier in Warm Springs, Georgia, April 12, 1945.

National Park Service: Despite President Roosevelt’s death just twelve days earlier, the United Nations Conference on International Organization in San Francisco stayed on schedule, beginning on April 25th and continuing through June 26th, 1945. On the opening day of the peace conference, 268 delegates, representing 46 nations, gathered in San Francisco’s War Memorial Opera House to begin their first session. The tone of the event was solemn, as the loss of President Roosevelt was still very much on everyone’s mind and the war was not yet officially over.  The photo below shows the United Nations delegates gathering at “Bohemian Grove.”

UNITED NATIONS BOHEMIAN GROVE 1945

Szeming Sze’s motion to create a World Health Organization in 1945 was tabled temporarily. “The International Health Conference was held in New York from 19 June to 22 July 1946. In four and a half weeks the Conference succeeded in producing: the Constitution of the World Health Organization.” World Health Organization

END